'Not Going With The Crowd’: Mapping Gene Potential With ProFound Therapeutics

Atlas Of Novel Protein Sequences For Discovering First-In-Class Medicines Innovations

John Lepore, CEO of ProFound Therapeutics and CEO-partner at Flagship Pioneering, discusses the vast possibilities for the human atlas, the benefits of strategic partnering and knowing when to walk away from a project.  

Genetics
• Source: Shutterstock

Flagship Pioneering, the self-described venture creation company, initiated ProFound Therapeutics four years ago with $75m funding and an undisclosed cash runaway.

"The scientific opportunity here is really unparalleled. It’s stepping into an incredible possibility,” said John Lepore, as he explained his...

More from Innovation

More from In Vivo